Search Results

ST034307 100mg  | ≥99%

CSNpharm

ST034307 is an adenylyl cyclase 1 (AC1) inhibitor (IC50 = 2.3 μM), which exhibits some selectivity for AC1 over other AC isoforms.

More Information Supplier Page

Urolithin A 5mg  | ≥99%

CSNpharm

Urolithin A is a metabolite of ellagitannin with antiproliferative and antioxidant properties. It can cross the blood brain barrier, and may have neuroprotective effects against Alzheimer’s Disease.

More Information Supplier Page

Urolithin A 25mg  | ≥99%

CSNpharm

Urolithin A is a metabolite of ellagitannin with antiproliferative and antioxidant properties. It can cross the blood brain barrier, and may have neuroprotective effects against Alzheimer’s Disease.

More Information Supplier Page

Urolithin A 100mg  | ≥99%

CSNpharm

Urolithin A is a metabolite of ellagitannin with antiproliferative and antioxidant properties. It can cross the blood brain barrier, and may have neuroprotective effects against Alzheimer’s Disease.

More Information Supplier Page

S107 1mg  | ≥99%

CSNpharm

S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

S107 5mg  | ≥99%

CSNpharm

S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

S107 100mg  | ≥99%

CSNpharm

S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page